Search


CMC and margins make cell and gene therapy a different kind of medicine
Dark Horse Consulting's Anthony Davies discusses CMC issues to consider when developing cell and gene therapies.
Jan 18, 2023
Also look for unique social pages for BiotechTV U.
Genezen is a contract development and manufacturing organization (CDMO) with unique technical expertise in lentiviral, retroviral, and adeno-associated viral vectors. Offering process development, GMP viral vector manufacturing, and analytics, we are dedicated to helping you deliver safe, pure, and potent advanced therapies to the patients who need them.